Chengdu Kaijie Biopharm Co. Ltd. (kjbp)

Country/Region: China     State/Province: Sichuan

Main Products: Peptide

Company Introduction
Chengdu Kaijie Biopharm Co. Ltd. (KJBP) is one of the leading peptide manufacturers in China. It was founded in Chengdu in March, 2003 by a team of experienced peptide chemists with a combined industrial experience over 20 years. KJBP has oriented its business along two main lines:the investigation, development, production and commercialization of generic bulk peptide APIs for the international markets, and custom synthesis service for buliding blocks, amino acid resin and peptide sequences which meet researchers€™ specific demand worldwide.Dayi campus in the suburb of Chengdu city provides KJBP with a good infrastructure for both industrial-scale production of peptides and Custom pharmaceutical grade solid phase peptide synthesis in Dayi campus can meet USP, EP or the requirements of CP, single batches are up to Kg scales. KJBP has begun to implement the 2008 development plan which is improving quality management standards and increasing production Chinese GMP is accomplished and the US FDA preparatory work is also under way as scheduled.Our MissionTo combine innovation with excellence by developing and manufacturing quality peptide accompanied by professional and friendly scientific support.
Company Overview

Business Type: Exporter, Retailer

Year Established: 2003

Employees: 201 - 300 People

Plant Area: 5,000-10,000 square meters

Contact Information

Fax: 86-028-88203632

Business Information

Main Markets: South America 12% Africa 11% Eastern Asia 9% Domestic Market 9% North America 11% Eastern Europe 9% Southern Europe 12% Mid East 10% Northern Europe 11% Oceania 6%

Trade Capacity: FOB, FCA, DES

Contract Manufacturing: OEM Service Offered ,Design Service Offered

Nearest Port: Chengdu

Trade & Financial Information

Annual Revenue: US$1 Million - US$2.5 Million

Total Revenue: US$1 Million - US$2.5 Million

Export Revenue: US$5 Million - US$10 Million

Annual Output: US$10 Million - US$50 Million

Registered Capital: US$50 Million - US$100 Million

Export Percentage: 31% - 40%

Payment Modes: USD, JPY, GBP

Lead Time: 21 days

Import/Export Mode: Have Own Export License

Product Showcase
peptide

CL-Link > Health & Medicines in China Health & Medicines in Sichuan Health Care Supplement in China Health Care Supplement in Sichuan Dolutegravir in China Dolutegravir in Sichuan